There are significant disparities that influence prevalence, metabolic control, complication rates, and outcomes in diabetes. Disparities in diabetes are experienced on the basis of: race/ethnicity, gender, socioeconomic status, age-related vulnerabilities across the lifespan (both young and older adults), presence of co-morbidities (e.g., depressed persons with diabetes), and geography (e.g., rural vs. urban). Inequities in diabetes are especially pervasive and persistent in the Southeastern United States. Disparities occur, at least in part, due to inadequate capacity building for translating successful diagnostic, preventive, and therapeutic modalities for individuals and communities at greatest risk. The Atlanta metropolitan area has a rich and diverse population of Black, Hispanic, and South Asian minorities, low socioeconomic status, and low-access communities who have the highest burdens of diabetes in the country. Therefore, the overall goal of the Georgia Diabetes Translation Research Center's Core D (Disparities) is to facilitate more combined diabetes-disparities translation research that can identify ways to improve engagement in evidence-based diabetes prevention and management interventions among vulnerable populations, and reduce the disproportionately higher risks of morbidity and mortality from diabetes in these groups. To accomplish these goals, Core D has assembled a talented and expert team of Faculty that have tremendous experience in conducting federally-funded disparities and translation research. Core D will expand the spectrum of disparities addressed by including the well-known gender and race/ethnic inequities, but also diabetes throughout the lifespan (e.g., adolescent challenges in medication adherence, gestational diabetes, and older adults that contend with multiple co- existing morbidities), and people with diabetes who have a variety of co-morbidities that dramatically increase their risk of adverse outcomes, including cardiovascular disease, depression, cognitive decline, and HIV. Core D provides methodological expertise, sociocultural competencies, access to populations in community and clinical settings, and relevant databases, tools, and technologies that help investigators explore the drivers of disparities and avenues to address them. Core D leverages Emory University, Georgia Tech, and Morehouse School of Medicine's impressive history of collaboration and longstanding work in disparities research. In particular, these institutions have successfully established large research and community platforms for health equity research with funding from the National Institutes of Health, the Centers for Disease Control and Prevention, and the American Heart Association. All of these will be leveraged as platforms for new and ongoing diabetes translation research. Core D offers a comprehensive and diverse set of clinical research environments, ranging from hospitals and clinics, a Veterans Administration hospital, an inner city hospital (Grady Memorial), and community clinics in at-risk neighborhoods. Core D Faculty will be active GDTRC members, contributing to discourse on research, reducing disparities, and disseminating tools and findings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK111024-02
Application #
9353791
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Umpierrez, Guillermo E; Cardona, Saumeth; Chachkhiani, David et al. (2018) A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc 19:399-404.e3
Cha, EunSeok; Paul, Sudeshna; Braxter, Betty J et al. (2018) Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes. Diabetes Educ 44:158-167
Umpierrez, Guillermo E; Klonoff, David C (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 41:1579-1589
Gomez-Peralta, Fernando; Abreu, Cristina; Gomez-Rodriguez, Sara et al. (2018) Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios. Diabetes Ther 9:1775-1789
Vellanki, Priyathama; Umpierrez, Guillermo E (2018) Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care 41:1839-1841
Davis, Georgia; Fayfman, Maya; Reyes-Umpierrez, David et al. (2018) Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications 32:305-309
Ogilvie, Rachel P; Patel, Shivani A; Narayan, K M Venkat et al. (2018) Are the U.S. territories lagging behind in diabetes care practices? Prim Care Diabetes 12:432-437
Schultz, William M; Kelli, Heval M; Lisko, John C et al. (2018) Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions. Circulation 137:2166-2178
Spanakis, Elias K; Levitt, David L; Siddiqui, Tariq et al. (2018) The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol 12:20-25
Klonoff, David C; Umpierrez, Guillermo E; Rice, Mark J (2018) A Milestone in Point of Care Capillary Blood Glucose Monitoring of Critically Ill Hospitalized Patients. J Diabetes Sci Technol 12:1095-1100

Showing the most recent 10 out of 30 publications